SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.35%478.44M | 15.14%463.5M | 12.75%341.39M | 3.98%1.66B | 16.03%519.79M | 0.00%433.56M | -4.16%402.56M | 3.12%302.8M | 1.6B | 448M |
Operating revenue | 10.35%478.44M | 15.14%463.5M | 12.75%341.39M | 3.98%1.66B | 16.03%519.79M | 0.00%433.56M | -4.16%402.56M | 3.12%302.8M | --1.6B | --448M |
Cost of revenue | 10.09%200.71M | 6.11%199.19M | 4.01%146.58M | -13.98%715.53M | -27.19%204.57M | -13.66%182.31M | -6.58%187.73M | 1.56%140.93M | 831.82M | 280.96M |
Gross profit | 10.54%277.73M | 23.03%264.31M | 20.35%194.81M | 23.55%943.19M | 88.72%315.23M | 12.97%251.25M | -1.94%214.84M | 4.53%161.87M | 763.4M | 167.04M |
Operating expense | 9.88%208.09M | 19.68%196.89M | 15.14%169M | 12.67%717.73M | 2.99%217.08M | 23.02%189.37M | 9.12%164.51M | 20.73%146.77M | 637.04M | 210.78M |
Selling and administrative expenses | 9.88%208.09M | 19.68%196.89M | 15.14%169M | 12.67%717.73M | 2.99%217.08M | 23.02%189.37M | 9.12%164.51M | 20.73%146.77M | --637.04M | --210.78M |
Operating profit | 12.54%69.64M | 33.95%67.42M | 71.00%25.82M | 78.42%225.46M | 324.39%98.15M | -9.63%61.88M | -26.36%50.33M | -54.65%15.1M | 126.36M | -43.74M |
Net non-operating interest income expense | 234.74%384K | 25.03%-548K | 210.94%659K | 78.91%-942K | 153.65%668K | 80.94%-285K | 23.85%-731K | 22.45%-594K | -4.47M | -1.25M |
Total other finance cost | -234.74%-384K | -25.03%548K | -210.94%-659K | -78.91%942K | -153.65%-668K | -80.94%285K | -23.85%731K | -22.45%594K | --4.47M | --1.25M |
Other net income (expense) | 200.72%4.06M | -68.57%391K | -68,450.00%-4.1M | 125.01%1.43M | -35.04%4.21M | 44.62%-4.03M | 121.36%1.24M | -99.33%6K | -5.72M | 6.48M |
Other non- operating income (expenses) | 200.72%4.06M | -68.57%391K | -68,450.00%-4.1M | 125.01%1.43M | -35.04%4.21M | 44.62%-4.03M | 121.36%1.24M | -99.33%6K | ---5.72M | --6.48M |
Income before tax | 28.70%74.08M | 32.29%67.26M | 54.20%22.38M | 94.48%225.95M | 367.59%103.03M | -3.57%57.56M | -17.41%50.84M | -56.59%14.51M | 116.18M | -38.5M |
Income tax | 19.41%17.8M | 32.05%16.87M | 65.23%6.52M | 111.68%56.06M | 327.02%24.44M | 5.17%14.9M | -16.58%12.77M | -49.20%3.95M | 26.48M | -10.77M |
Net income | 31.95%56.28M | 32.37%50.4M | 50.09%15.86M | 89.41%169.89M | 383.34%78.59M | -6.29%42.66M | -17.69%38.07M | -58.83%10.56M | 89.69M | -27.74M |
Net income continuous Operations | 31.95%56.28M | 32.37%50.4M | 50.09%15.86M | 89.41%169.89M | 383.34%78.59M | -6.29%42.66M | -17.69%38.07M | -58.83%10.56M | --89.69M | ---27.74M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 31.95%56.28M | 32.37%50.4M | 50.09%15.86M | 89.41%169.89M | 383.34%78.59M | -6.29%42.66M | -17.69%38.07M | -58.83%10.56M | 89.69M | -27.74M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 31.95%56.28M | 32.37%50.4M | 50.09%15.86M | 89.41%169.89M | 383.34%78.59M | -6.29%42.66M | -17.69%38.07M | -58.83%10.56M | 89.69M | -27.74M |
Basic earnings per share | 34.69%0.66 | 34.09%0.59 | 50.00%0.18 | 88.46%1.96 | 381.25%0.9 | -7.55%0.49 | -18.52%0.44 | -58.62%0.12 | 1.04 | -0.32 |
Diluted earnings per share | 34.69%0.66 | 34.09%0.59 | 50.00%0.18 | 88.35%1.94 | 381.25%0.9 | -5.77%0.49 | -16.98%0.44 | -58.62%0.12 | 1.03 | -0.32 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |